Business and Finance Business and Finance
Thu, October 6, 2011

United Health Products Announces Agreement for SINC Ventures to Distribute Its Gauze Products


Published on 2011-10-06 07:45:41 - Market Wire
  Print publication without navigation


October 06, 2011 10:35 ET

United Health Products Announces Agreement for SINC Ventures to Distribute Its Gauze Products

SINC Ventures Will Distribute Epic Wound Care's Gauze Products to Amateur and Professional Sports Teams and Related Markets

NEW YORK, NY--(Marketwire - Oct 6, 2011) - United Health Products, Inc. (OTCQB: [ UEEC ]) (PINKSHEETS: [ UEEC ]), which develops and markets products and technologies in the healthcare sector, today announced that has engaged SINC Ventures LLC to provide distribution and marketing services to its Epic Wound Care subsidiary. SINC Ventures is a Utah based company which markets to the sports related industry focusing on sports training through a trainer network, with a customer base that includes professional, collegiate, high school, youth and club teams. SINC Ventures has identified potential customers within its network of trainers and intends on using its sales and marketing team comprised of former professional, collegiate athletes and trainers to introduce and demonstrate the key indications of the gauze.

Dr. Phillip Forman, CEO of United Health Products, commented, "United and Epic are delighted with SINC Ventures and we look forward to rapidly develop our brand with their support and effort."

"We are excited over the opportunity to utilize this product in this arena," said Steve Smith, President of SINC Venture LLC.

"We are pleased to be able to offer the gauze products to our customer base," added Marcus Mailei, SINC Venture Chief Operating Officer.

About United Health Products, Inc.

United Health Products, Inc. (UEEC) develops, manufactures and markets products and technologies in the healthcare sector. UEEC's principal operating subsidiary is Epic Wound Care, Inc. which produces a hemostatic gauze, derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds. The Company is focused on identifying emerging healthcare products and technologies for strategic partnership or acquisition.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.


Contributing Sources